Baseline lung function (mean % predicted with range) and mean coefficient of variation (%) with adjusted mean (95% CI) at end of treatment with fluticasone propionate and placebo. Also included are estimated mean treatment differences (fluticasone propionate minus placebo) with 95% CI. Values of p > 0.05 are considered non-significant (NS)
| FVC (%) | FEV1(%) | MEF25%(%) | Oxygen saturation (%) | |
|---|---|---|---|---|
| Baseline | 75 (45 to 107) | 64 (21 to 102) | 35 (8 to 73) | 95 (90 to 98) |
| Coefficient of variation (%) | 7 | 9 | 24 | – |
| Fluticasone propionate | 78 (74 to 83) | 65 (61 to 69) | 25 (15 to 36) | 95.0 (94.6 to 95.3) |
| Placebo | 78 (73 to 82) | 67 (63 to 71) | 40 (30 to 50) | 95.4 (95.0 to 95.8) |
| Estimated mean treatment difference | 0.5 (−6 to 7) | −2 (−8 to 4) | −15 (−26 to −4) | −0.4 (−1.0 to 0.1) |
| p Value | NS | NS | 0.009 | NS |